Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 2
1983 1
1984 1
1985 4
1988 1
1989 4
1990 2
1991 3
1992 4
1993 3
1994 4
1996 4
1997 7
1998 1
1999 6
2000 1
2001 5
2002 1
2004 1
2005 4
2006 9
2007 5
2008 5
2009 4
2010 9
2011 6
2012 7
2013 7
2014 8
2015 5
2016 12
2017 7
2018 7
2019 4
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

138 results
Results by year
Filters applied: . Clear all
Page 1
Blood pressure in early autosomal dominant polycystic kidney disease.
Schrier RW, Abebe KZ, Perrone RD, Torres VE, Braun WE, Steinman TI, Winklhofer FT, Brosnahan G, Czarnecki PG, Hogan MC, Miskulin DC, Rahbari-Oskoui FF, Grantham JJ, Harris PC, Flessner MF, Bae KT, Moore CG, Chapman AB; HALT-PKD Trial Investigators. Schrier RW, et al. Among authors: Flessner MF. N Engl J Med. 2014 Dec 11;371(24):2255-66. doi: 10.1056/NEJMoa1402685. Epub 2014 Nov 15. N Engl J Med. 2014. PMID: 25399733 Free PMC article. Clinical Trial.
Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney Disease.
Yu ASL, Shen C, Landsittel DP, Harris PC, Torres VE, Mrug M, Bae KT, Grantham JJ, Rahbari-Oskoui FF, Flessner MF, Bennett WM, Chapman AB; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP). Yu ASL, et al. Among authors: Flessner MF. Kidney Int. 2018 Mar;93(3):691-699. doi: 10.1016/j.kint.2017.09.027. Epub 2017 Dec 28. Kidney Int. 2018. PMID: 29290310 Free PMC article. Clinical Trial.
Angiotensin blockade in late autosomal dominant polycystic kidney disease.
Torres VE, Abebe KZ, Chapman AB, Schrier RW, Braun WE, Steinman TI, Winklhofer FT, Brosnahan G, Czarnecki PG, Hogan MC, Miskulin DC, Rahbari-Oskoui FF, Grantham JJ, Harris PC, Flessner MF, Moore CG, Perrone RD; HALT-PKD Trial Investigators. Torres VE, et al. Among authors: Flessner MF. N Engl J Med. 2014 Dec 11;371(24):2267-76. doi: 10.1056/NEJMoa1402686. Epub 2014 Nov 15. N Engl J Med. 2014. PMID: 25399731 Free PMC article. Clinical Trial.
Patterns of Kidney Function Decline in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis From the HALT-PKD Trials.
Brosnahan GM, Abebe KZ, Moore CG, Rahbari-Oskoui FF, Bae KT, Grantham JJ, Schrier RW, Braun WE, Chapman AB, Flessner MF, Harris PC, Hogan MC, Perrone RD, Miskulin DC, Steinman TI, Torres VE; HALT-PKD Trial Investigators. Brosnahan GM, et al. Among authors: Flessner MF. Am J Kidney Dis. 2018 May;71(5):666-676. doi: 10.1053/j.ajkd.2017.10.023. Epub 2018 Jan 3. Am J Kidney Dis. 2018. PMID: 29306517 Free PMC article. Clinical Trial.
Dietary salt restriction is beneficial to the management of autosomal dominant polycystic kidney disease.
Torres VE, Abebe KZ, Schrier RW, Perrone RD, Chapman AB, Yu AS, Braun WE, Steinman TI, Brosnahan G, Hogan MC, Rahbari FF, Grantham JJ, Bae KT, Moore CG, Flessner MF. Torres VE, et al. Among authors: Flessner MF. Kidney Int. 2017 Feb;91(2):493-500. doi: 10.1016/j.kint.2016.10.018. Epub 2016 Dec 16. Kidney Int. 2017. PMID: 27993381 Free PMC article. Clinical Trial.
Effect of Statin Therapy on the Progression of Autosomal Dominant Polycystic Kidney Disease. A Secondary Analysis of the HALT PKD Trials.
Brosnahan GM, Abebe KZ, Rahbari-Oskoui FF, Patterson CG, Bae KT, Schrier RW, Braun WE, Chapman AB, Flessner MF, Harris PC, Perrone RD, Steinman TI, Torres VE; HALT PKD Investigators. Brosnahan GM, et al. Among authors: Flessner MF. Curr Hypertens Rev. 2017;13(2):109-120. doi: 10.2174/1573402113666170427142815. Curr Hypertens Rev. 2017. PMID: 28460625 Free PMC article.
Glomerular Diseases: Registries and Clinical Trials.
Moxey-Mims MM, Flessner MF, Holzman L, Kaskel F, Sedor JR, Smoyer WE, Thompson AM, Yao L. Moxey-Mims MM, et al. Among authors: Flessner MF. Clin J Am Soc Nephrol. 2016 Dec 7;11(12):2234-2243. doi: 10.2215/CJN.00540116. Epub 2016 Sep 26. Clin J Am Soc Nephrol. 2016. PMID: 27672219 Free PMC article.
ADPKD Progression in Patients With No Apparent Family History and No Mutation Detected by Sanger Sequencing.
Braun WE, Abebe KZ, Brosnahan G, Patterson CG, Chapman AB, Harris PC, Hogan MC, Perrone RD, Torres VE, Miskulin DC, Steinman TI, Winklhofer FT, Rahbari-Oskoui FF, Czarnecki PG, Bae KT, Grantham JJ, Flessner MF, Schrier RW. Braun WE, et al. Among authors: Flessner MF. Am J Kidney Dis. 2018 Feb;71(2):294-296. doi: 10.1053/j.ajkd.2017.09.008. Epub 2017 Dec 2. Am J Kidney Dis. 2018. PMID: 29203126 Free PMC article. No abstract available.
Pragmatic Trials in Maintenance Dialysis: Perspectives from the Kidney Health Initiative.
Dember LM, Archdeacon P, Krishnan M, Lacson E Jr, Ling SM, Roy-Chaudhury P, Smith KA, Flessner MF. Dember LM, et al. Among authors: Flessner MF. J Am Soc Nephrol. 2016 Oct;27(10):2955-2963. doi: 10.1681/ASN.2016030340. Epub 2016 Jul 11. J Am Soc Nephrol. 2016. PMID: 27401689 Free PMC article. Review.
Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD.
Isakova T, Ix JH, Sprague SM, Raphael KL, Fried L, Gassman JJ, Raj D, Cheung AK, Kusek JW, Flessner MF, Wolf M, Block GA. Isakova T, et al. Among authors: Flessner MF. J Am Soc Nephrol. 2015 Oct;26(10):2328-39. doi: 10.1681/ASN.2015020117. Epub 2015 May 12. J Am Soc Nephrol. 2015. PMID: 25967123 Free PMC article. Review.
138 results
Jump to page
Feedback